Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]
News [6431]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
Doubled survival in metastatic lung cancer with combination therapy
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Combined immuno-chemotherapy improves survival and responses in metastatic lung...
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Results from CheckMate-227 : Immune combination reaches PFS endpoint
Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 : Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
Comment: Urothelial cancer research from ASCO GU 2018
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and...
Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK
VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )
9 Feb 2018
Genomic profiling of muscle invasive bladder cancer to predict response to...
Dr David Miyamoto - Massachusetts General Hospital, Boston, USA
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy ( Dr David Miyamoto - Massachusetts General Hospital, Boston, USA )
9 Feb 2018
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in...
Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...
Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )
9 Feb 2018
Detection and clinical significance of dense breast tissue
Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia
Detection and clinical significance of dense breast tissue ( Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia )
6 Feb 2018
New trends in breast cancer radiotherapy
Prof Fady Geara - American University of Beirut Medical Center, Beirut, Lebanon
New trends in breast cancer radiotherapy ( Prof Fady Geara - American University of Beirut Medical Center, Beirut, Lebanon )
29 Jan 2018
Immunotherapy and targeted treatments in breast cancer reviewed
Dr Hesham El Ghazaly and Prof Leisha Emens
Immunotherapy and targeted treatments in breast cancer reviewed ( Dr Hesham El Ghazaly and Prof Leisha Emens )
29 Jan 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation